Antineoplastic Effect | List of Frontiers open access articles

Original Research

Published on 18 Dec 2018

Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration

in Thyroid Endocrinology

Silvia Martina Ferrari
Concettina La Motta
Giusy Elia
Francesca Ragusa
Ilaria Ruffilli
Luca Quattrini
Sabrina Rosaria Paparo
Simona Piaggi
Armando Patrizio
Salvatore Ulisse

Frontiers in Endocrinology

doi 10.3389/fendo.2018.00764

4,549 views
26 citations

Original Research

Published on 05 Jun 2020

Oxymatrine Inhibits Renal Cell Carcinoma Progression by Suppressing β-Catenin Expression

in Pharmacology of Anti-Cancer Drugs

Yinshan Jin
Jiannan Liu
Yadong Liu
Yang Liu
Guiying Guo
Shiliang Yu
Ruihua An

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00808

4,097 views
11 citations

Original Research

Accepted on 19 Feb 2026

Loss of Inducible Nitric Oxide Synthase Promotes Kras/Pten-driven Lung Tumorigenesis

in Cancer Cell Biology

Zahra Kabiri
Hamed Zaribafzadeh
Sara Raji
John M Carney
Christopher M Counter

Frontiers in Cell and Developmental Biology

Original Research

Published on 11 May 2022

RRM2 Mediates the Anti-Tumor Effect of the Natural Product Pectolinarigenin on Glioblastoma Through Promoting CDK1 Protein Degradation by Increasing Autophagic Flux

in Cancer Molecular Targets and Therapeutics

Haiping Jiang
Dongzhi Zhang
Karpov Denis Aleksandrovich
Junyi Ye
Lixiang Wang
Xiaofeng Chen
Ming Gao
Xinzhuang Wang
Tao Yan
He Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.887294

5,227 views
18 citations

Original Research

Published on 01 Oct 2021

Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53–PUMA Apoptosis Pathway

in Neuro-Oncology and Neurosurgical Oncology

Hong-Chieh Tsai
Kuo-Chen Wei
Pin-Yuan Chen
Chiung-Yin Huang
Ko-Ting Chen
Ya-Jui Lin
Hsiao-Wei Cheng
Yi-Rou Chen
Hsiang-Tsui Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.722754

5,927 views
29 citations

Original Research

Published on 20 Jun 2023

Adjuvant composite cold atmospheric plasma therapy increases antitumoral effect of doxorubicin hydrochloride

in Pharmacology of Anti-Cancer Drugs

Volha Kniazeva
Dzmitry Tzerkovsky
Ömür Baysal
Alexander Kornev
Evgeny Roslyakov
Serhei Kostevitch

Frontiers in Oncology

doi 10.3389/fonc.2023.1171042

4,056 views
8 citations

Original Research

Published on 20 Mar 2024

Antineoplastic effect of compounds C14 and P8 on TNBC and radioresistant TNBC cells by stabilizing the K-Ras4BG13D/PDE6δ complex

in Molecular and Cellular Oncology

Dayan A. Carrión-Estrada
Arturo Aguilar-Rojas
Sara Huerta-Yepez
Mayra Montecillo-Aguado
Martiniano Bello
Arturo Rojo-Domínguez
Elena Arechaga-Ocampo
Paola Briseño-Díaz
Marco Antonio Meraz-Ríos
María del Rocío Thompson-Bonilla

Frontiers in Oncology

doi 10.3389/fonc.2024.1341766

5,339 views
1 citation

Original Research

Published on 12 May 2020

Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro

in Pharmacology of Anti-Cancer Drugs

Yuqi Yang
Ning Ji
Qiu-Xu Teng
Chao-Yun Cai
Jing-Quan Wang
Zhuo-Xun Wu
Zi-Ning Lei
Sabrina Lusvarghi
Suresh V. Ambudkar
Zhe-Sheng Chen

Frontiers in Oncology

doi 10.3389/fonc.2020.00700

8,357 views
37 citations

Original Research

Published on 06 Apr 2022

SHP2 Inhibitors Show Anti-Myeloma Activity and Synergize With Bortezomib in the Treatment of Multiple Myeloma

in Pharmacology of Anti-Cancer Drugs

Pan Zhou
Mengyu Xiao
Weiya Li
Xiaobai Sun
Yanliang Bai
Feiying Meng
Zunmin Zhu
Weiping Yuan
Kai Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2022.841308

5,357 views
5 citations

Original Research

Published on 26 Jun 2020

Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients

in Pharmacology of Anti-Cancer Drugs

Zulfan Zazuli
Renate Kos
Joris D. Veltman
Wilma Uyterlinde
Cristina Longo
Paul Baas
Rosalinde Masereeuw
Susanne J. H. Vijverberg
Anke-Hilse Maitland-van der Zee

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00975

4,528 views
5 citations

Articles

Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration

Oxymatrine Inhibits Renal Cell Carcinoma Progression by Suppressing β-Catenin Expression

Loss of Inducible Nitric Oxide Synthase Promotes Kras/Pten-driven Lung Tumorigenesis

RRM2 Mediates the Anti-Tumor Effect of the Natural Product Pectolinarigenin on Glioblastoma Through Promoting CDK1 Protein Degradation by Increasing Autophagic Flux

Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53–PUMA Apoptosis Pathway

Adjuvant composite cold atmospheric plasma therapy increases antitumoral effect of doxorubicin hydrochloride

Antineoplastic effect of compounds C14 and P8 on TNBC and radioresistant TNBC cells by stabilizing the K-Ras4BG13D/PDE6δ complex

Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro

SHP2 Inhibitors Show Anti-Myeloma Activity and Synergize With Bortezomib in the Treatment of Multiple Myeloma

Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients